CBD and NSAIDs: ibuprofen, naproxen, diclofenac — what the CYP2C9 evidence means
Bottom line. Most NSAIDs are CYP2C9-metabolized, and CBD inhibits CYP2C9. For occasional OTC-dose ibuprofen or naproxen, the interaction risk is low but present. For chronic prescription-dose NSAIDs (diclofenac, indomethacin, celecoxib), the concern is higher — both from CYP2C9 overlap and from the dose-dependent GI and cardiovascular risks that follow higher NSAID plasma levels. Note: celecoxib has its own spoke — see CBD and Celebrex.
Key takeaways
- Most NSAIDs (ibuprofen, naproxen, diclofenac) are CYP2C9-dependent; CBD inhibits CYP2C9.
- Occasional OTC-dose NSAIDs with CBD: low but non-zero risk — CYP inhibition is dose-dependent.
- Chronic prescription NSAIDs with CBD: higher concern — warrants a prescriber conversation.
- Aspirin (low-dose, COX-1 irreversible) is not a CYP2C9 substrate and has a different interaction profile.
- The GI and cardiovascular risks of NSAIDs are dose-dependent — raised plasma levels compound these.
What the science says
Bansal 2023's n=18 RCT confirmed CBD raises CYP2C9 substrate plasma exposure significantly at research doses. Stöllberger 2023's review of 403 CYP-substrate drugs lists ibuprofen, naproxen, and diclofenac as CYP2C9 substrates with meaningful CBD overlap. No NSAID-specific case reports in the literature parallel the Cortopassi warfarin case — but the mechanism is the same enzyme.
Per-NSAID profile
| NSAID | Brand | CYP metabolism | CBD concern |
|---|---|---|---|
| Ibuprofen | Advil, Motrin | CYP2C9 (primary) | Low-moderate; OTC occasional use lower risk |
| Naproxen | Aleve, Naprosyn | CYP2C9 (primary) | Low-moderate; similar profile to ibuprofen |
| Diclofenac | Voltaren | CYP2C9 (primary) | Moderate — prescription-dose, longer half-life |
| Indomethacin | Indocin | CYP2C9 + glucuronidation | Moderate — prescription, complex metabolism |
| Celecoxib | Celebrex | CYP2C9 (COX-2 selective) | Moderate — see dedicated page |
| Aspirin (low-dose) | Bayer, generic | Not CYP2C9 (esterase, glucuronidation) | Lower pharmacokinetic risk; different mechanism |
Context matters: OTC vs chronic prescription use
The interaction risk is dose-dependent and context-dependent. Taking 400mg ibuprofen once or twice for a headache while using CBD daily is unlikely to produce a clinically significant effect — the CBD's CYP2C9 inhibition slows ibuprofen clearance somewhat, but the short duration and low dose mean the cumulative exposure change is minimal.
Taking 800mg ibuprofen three times daily for chronic arthritis pain while on CBD is a different calculation: chronic NSAID use already carries GI (gastric ulceration) and cardiovascular (blood pressure, platelet) risk that is dose-dependent. If CBD consistently raises NSAID plasma levels, those risks compound. This is the scenario that warrants a prescriber conversation.
What this means for you
- Occasional OTC NSAIDs: Low risk. Use the lowest effective dose and shortest duration — which is the right guidance for NSAIDs regardless of CBD.
- Chronic prescription NSAIDs: Tell your prescriber. Mention your CBD dose and format. The prescriber can assess whether monitoring makes sense.
- GI protection. If you take chronic NSAIDs, you may already be on a proton pump inhibitor. This remains appropriate regardless of CBD.
- Consider the NANO roll-on. For localized joint pain — which is often why people reach for ibuprofen — the NANO roll-on is a topical option that doesn't carry GI risk and has minimal systemic CYP exposure. It's not a substitute for systemic anti-inflammatory therapy, but for local muscle and joint use, it's a different risk profile.
Frequently asked questions
Can I take CBD with ibuprofen or naproxen?
Occasionally at OTC doses: low risk but not zero. Ibuprofen and naproxen use CYP2C9; CBD inhibits CYP2C9. For chronic prescription-dose use, the concern is higher and warrants a prescriber conversation.
Can CBD replace NSAIDs?
We cannot recommend CBD as an NSAID replacement — that is a therapeutic claim the current evidence doesn't fully support. CBD may complement joint comfort care but do not stop NSAIDs without your prescriber's guidance.
Does CBD and ibuprofen combination increase GI risk?
Possibly indirectly: if CBD raises ibuprofen plasma levels via CYP2C9 inhibition, you're effectively getting a higher NSAID dose — which can worsen GI exposure. Take NSAIDs with food and use the lowest effective dose.
References
- Bansal S et al. (2023). Cannabidiol effects on the pharmacokinetics of substrates of cytochrome P450 enzymes. PMID 37313955
- Stöllberger C, Finsterer J. (2023). Interactions between cannabidiol and commonly used prescription drugs. PMID 37541924
- Nachnani R et al. (2024). Cannabidiol-prescription drug interactions: a systematic review. PMID 38868665